Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Watanabe

Showing results (361-370 of 363) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 363 results.
Respiratory Investigation|March 6, 2025
Analysis of risk factors for long COVID after mild COVID-19 during the Omicron wave in JapanHotaka Namie, Takahiro Takazono, Rina Kawasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 31, 2002
[Early phase II dose-finding study of exemestane in postmenopausal patients with advanced/recurrent breast cancer]Toshio Tabei, Masami Ogita, Kouichi Hirata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 1, 2018
Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in JapanNobuhisa Ishiguro, Naoko Koseki, Miki Kaiho, et al.
Pageof 37

Showing results (361-370 of 363) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 363 results.
Respiratory Investigation|March 6, 2025
Analysis of risk factors for long COVID after mild COVID-19 during the Omicron wave in JapanHotaka Namie, Takahiro Takazono, Rina Kawasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 31, 2002
[Early phase II dose-finding study of exemestane in postmenopausal patients with advanced/recurrent breast cancer]Toshio Tabei, Masami Ogita, Kouichi Hirata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 1, 2018
Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in JapanNobuhisa Ishiguro, Naoko Koseki, Miki Kaiho, et al.
Pageof 37